Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center
Lind M, Roncaioli S, Liu C, Bryan A, Sweet A, Tverdek F, Sorror M, Phipps A, Pergam S. Are hematopoietic cell transplant recipients with Gram‐negative bacteremia spending more time outpatient while on intravenous antibiotics? Addressing trends over 10 years at a single center. Immunity Inflammation And Disease 2021, 9: 1786-1794. PMID: 34289529, PMCID: PMC8589361, DOI: 10.1002/iid3.486.Peer-Reviewed Original ResearchConceptsGram-negative rod bacteremiaAllogeneic HCT recipientsOutpatient antibiotic treatmentHematopoietic cell transplantationHCT recipientsProportion of treatment timePosttransplant complicationsAntibiotic treatmentAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsOutpatient settingAntibiotic treatment timeBroad-spectrum antibioticsIntravenous antibioticsCell transplantationTransplant recipientsDays posttransplantationTreatment optionsTreatment timePatientsTreatment managementComplicationsInfection characteristicsRecipientsAmbulatory care setting